当前位置: X-MOL 学术Eur. J. Clin. Microbiol. Infect. Dis. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
High reproducibility of the interferon-gamma release assay T-SPOT.TB in serial testing.
European Journal of Clinical Microbiology & Infectious Diseases ( IF 3.7 ) Pub Date : 2020-08-08 , DOI: 10.1007/s10096-020-03997-3
Thomas Meier 1 , Martin Enders 1
Affiliation  

Longitudinal studies regarding the reproducibility of Interferon-gamma release assay (IGRA) T-SPOT.TB for the diagnosis of Mycobacterium tuberculosis (M. tb) infection in serial testing are limited. We retrospectively analysed results of serially tested subjects in a medical laboratory in Germany over a time period of 14 years. From October 2004 to December 2018, a total of 5440 subjects were identified with a second T-SPOT.TB test after a median time interval of 258 days (interquartile range [IQR] 62–665). Consistently negative (n = 4520) or positive results (n = 682) were observed in 5202 (95.6%) subjects, indicating a high degree of concordance in serial testing (κ = 0.83). Test conversions occurred in 101 of 4621 (2.2%) subjects with initially negative tests. Of 819 subjects with initially positive test results, 137 (16.7%) had a test reversion which was associated with low spot numbers of the first test. Of 529 subjects retested within 1 year, only 60 (11.3%) displayed a test reversion. In subjects retested after more than 1 year, 77 of 290 (26.6%) tests reverted. This significantly higher rate of test reversions after more than 1 year was age-dependent and only observed in subjects above the age of 40 years. In the medical laboratory, the T-SPOT.TB test demonstrates a high reproducibility in serial testing.



中文翻译:

干扰素-γ释放测定法T-SPOT.TB在串行测试中具有很高的重现性。

关于干扰素-γ释放测定(IGRA)T-SPOT的可重复性的纵向研究。TB为诊断结核分枝杆菌结核分枝杆菌)感染的串行测试是有限的。我们回顾性分析了德国医学实验室历时14年的连续测试受试者的结果。从2004年10月到2018年12月,共有5440名受试者被确定为第二次T-SPOT。中位时间间隔为258天(四分位间距[IQR] 62-665)后进行TB测试。 在5202名(95.6%)受试者中观察到始终为阴性(n  = 4520)或阳性结果(n = 682),这表明在系列测试中高度一致(κ = 0.83)。测试转换发生在4621位(101%)受试者中的101位最初为阴性测试。在819名最初测试结果呈阳性的受试者中,有137名(16.7%)的测试回复与第一次测试的低点数相关。在1年内重新测试的529位受试者中,只有60位(11.3%)表现出测试反转。在超过一年后重新测试的受试者中,290个测试中有77个(26.6%)恢复了测试。超过1年的测试复归率明显更高,这取决于年龄,并且仅在40岁以上的受试者中观察到。在医学实验室,是T-SPOT。TB测试证明了串行测试的高度可重复性。

更新日期:2020-08-08
down
wechat
bug